All Type of News
Drug agency to screen product monograph prior to marketing
The Korea Food and Drug Administration has recently unveiled its plan to screen the contents of a drug’s insert paper which include product summary, pharmacological action and active ingredients prior to its launching...
Zuellig, Hanwha Pharma agree to establish ties
Zuellig Pharma Korea has forged an alliance with Hanwha Pharmaceutical.
Under the deal, Zuellig will be in charge of distributing Hanwha over-the-counter (OTC) drugs and one health product using its extensive dome...
New Cinfa Korea president to start work
Laboratorios Cinfa, Spain's leading pharmaceutical company in sales by volume through retail pharmacies, and Spain's second leading pharmaceutical company, says that Lee Joo-chul, former executive of GlaxoSmithKline i...
Rheumatoid-arthritis drug Remicade price to be slashed
Janssen Korea said yesterday that its rheumatoid-arthritis medication Remicade 100 mg (infliximab) will be reduced by 3.9 percent to 557,332 won per bottle from Dec. 1 as the Ministry of Health and Welfare has decided...
Health insurance to cover 73 drugs
The Ministry of Health and Welfare said Monday that a total of 73 generic drugs, including Handok’s Amaryl-M (metformin HCl), will be covered by the national health insurance from Dec. 1.
The ministry also said tha...
Most firms sweating on product restructuring
A majority of Korean pharmaceutical companies are still struggling to finalize their product restructuring plans for the new year, according to pharmaceutical industry sources
The government’s large price cut plan ...
New factor Xa inhibitor shows promiseGreen Cross Corp. said Wednesday it has received approval from the U.S. Food and Drug Administration to conduct Phase 1 clinical trial of a novel anti-thrombotic which can be cl...
|
Health minister, FKCU to meet over drug pricing reform
Attention has been drawn over the proposed meeting between Health and Welfare Minister Rim Che-min and representatives from the Federation of Korean Chemical Workers Union (FKCU) on December 7.
So far, the FKCU cla...
Drug makers stalling on 2012 business plan
Weighed down by the imminent large price cuts and Assembly’s ratification of the new Korea-U.S. free trade agreement, domestic pharmaceutical firms are delaying the formulation of their business plans for next year.
...
Patent linkage system will hurt pharmaceutical sector
The introduction of the patent linkage system following the ratification of the Korea-U.S. Free Trade Agreement is expected to deal a serious blow to the revenue of domestic drug makers.
In a local seminar on Tuesd...
